Dexamethasone and N-acetylcysteine (NAC)

Phase 3Small molecule

Dexamethasone and N-acetylcysteine (NAC) is one of 6 small molecule programs targeting Poisoning. It is currently in Phase 3.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

PoisoningRecruiting

PoisoningPhase 3

Recruiting

Competition

Competitive Landscape

5 competitors in Poisoning

#DrugCompanyPhaseTrials

Zofran

Novartis

Approved

1 2

Acetadote

AArbor Pharmaceuticals, Inc.

Approved

1 3

Dexamethasone and N-acetylcysteine (NAC)

CChina Medical University Hospital

Phase 3

1 4

Cortef

PPfizer's Upjohn has merged with Mylan to form Viatris Inc.

Preclinical

1 5

Sodium Nitrite

HHope Pharmaceuticals

Preclinical

—6

Lipid Emulsion

UUniversity of Rochester

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q3 2027

Post-ApprovalRecruiting

Poisoning

NCT06811675

Clinical

Trials by Indication[1]

Poisoning1 trial

The Efficacy of Dexamethasone in Combination With N-acetylcysteine in Preventing Neurocognitive Sequelae Due to Carbon Monoxide Poisoning

Recruiting·—·Phase 4·NCT06811675·128 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Dexamethasone and N-acetylcysteine (NAC). U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Dexamethasone and N-acetylcysteine (NAC) compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Dexamethasone and N-acetylcysteine (NAC). EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — China Medical University Hospital company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 3[1]
Company: CChina Medical University Hospital

Dexamethasone and N-acetylcysteine (NAC)

Status by Indication[3][1]

Competitive Landscape

Expected Milestones

Q3 2027

Trials by Indication[1]

Poisoning1 trial

References

Drug Info

Quick Facts

Related News